Skip to main content
Journal ArticleOPEN ACCESS

The Herby Study: a Phase 2 Open-Label, Randomized, Multicenter Study of Bevacizumab-Based Therapy in Pediatric Patients with Newly Diagnosed High-Grade Glioma

  • Grill J
  • Hargrave D
  • Varlet P
  • et al.
Annals of Oncology (2014) 25 iv145
DOI: 10.1093/annonc/mdu330.27
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

46th Congress of The International Society of Paediatric Oncology (SIOP) 2014 Toronto, Canada, 22nd–25th October

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Grill, J., Hargrave, D., Varlet, P., Jaspan, T., Jones, C., Massimino, M., … Vassal, G. (2014). The Herby Study: a Phase 2 Open-Label, Randomized, Multicenter Study of Bevacizumab-Based Therapy in Pediatric Patients with Newly Diagnosed High-Grade Glioma. Annals of Oncology, 25, iv145. https://doi.org/10.1093/annonc/mdu330.27

Readers' Seniority

Tooltip

Researcher 2

67%

PhD / Post grad / Masters / Doc 1

33%

Readers' Discipline

Tooltip

Philosophy 1

25%

Medicine and Dentistry 1

25%

Nursing and Health Professions 1

25%

Neuroscience 1

25%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 20

Save time finding and organizing research with Mendeley

Sign up for free